No CrossRef data available.
Published online by Cambridge University Press: 16 April 2020
To evaluate attitude and adhesion of psychiatric patients towards its treatment, specially psychotic patients with neuroleptic treatment
This is an open study on a population of 36 hospitalised patients in Acute Psychiatric Unit at Hospitality Center Benito Menni of Valladolid (Spain). Basic social-demographic information, characteristics of disease and treatment of each patient, their answers to an own questionnaire of quality assistance and scores derived from the application of Drug Attitude Inventory (DAI) has been collected in a protocolized form. These scores has been analysed with SSPS statistical program, crossing variables such as diagnosis or treatment.
Some results are detailed as follows:
Male 38,9%, female 61,1%. Mean age 52,89.Usually single 50% that live alone 54,6% in urban habitat 65,6%, majority with schizophrenia 27,8%, followed by depressive spectrum 22,2%., with a combination of anxiolytics (lormetazepam + lorazepam) 33,3%, and risperidone (22,2%) or olanzapine (27,8%) in most cases.
After analysis we found statistical significance in differences by gender – better in case of women -, diagnosis – better attitudes with higher scores in patients with non psychotic disorder - and atypical neuroleptic treatment.
1. Adherence and better attitudes were more likely in female patients, also schizophrenic, probably due to their caregivers role in society.
2. As expected, non psychotic patients with higher conscious of illness are more likely to see treatment as useful.
3. Atypical neuroleptics seems to be better in order to achieve proper treatment adherence
Comments
No Comments have been published for this article.